X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21977) 21977
Book Review (3816) 3816
Publication (1147) 1147
Newsletter (1088) 1088
Conference Proceeding (284) 284
Book Chapter (93) 93
Newspaper Article (60) 60
Magazine Article (53) 53
Trade Publication Article (22) 22
Dissertation (10) 10
Web Resource (10) 10
Book / eBook (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
infliximab (20384) 20384
humans (14235) 14235
index medicus (13875) 13875
female (8044) 8044
male (7845) 7845
adult (6303) 6303
antibodies, monoclonal - therapeutic use (6301) 6301
middle aged (5781) 5781
tumor necrosis factor-alpha - antagonists & inhibitors (5068) 5068
etanercept (4543) 4543
gastroenterology & hepatology (4533) 4533
treatment outcome (4385) 4385
rheumatology (4206) 4206
adalimumab (4173) 4173
therapy (3427) 3427
crohn's disease (3134) 3134
rheumatoid arthritis (3123) 3123
aged (2973) 2973
antirheumatic agents - therapeutic use (2931) 2931
arthritis, rheumatoid - drug therapy (2776) 2776
crohns-disease (2729) 2729
antibodies, monoclonal - adverse effects (2656) 2656
rheumatoid-arthritis (2656) 2656
inflammatory-bowel-disease (2641) 2641
crohn disease - drug therapy (2600) 2600
care and treatment (2311) 2311
ulcerative colitis (2271) 2271
inflammatory bowel disease (2143) 2143
monoclonal antibodies (2058) 2058
methotrexate (2001) 2001
adolescent (1953) 1953
efficacy (1950) 1950
drug therapy (1941) 1941
abridged index medicus (1766) 1766
double-blind (1757) 1757
young adult (1740) 1740
retrospective studies (1718) 1718
severity of illness index (1704) 1704
research (1690) 1690
dermatology (1623) 1623
anti-inflammatory agents - therapeutic use (1610) 1610
psoriasis (1587) 1587
arthritis (1586) 1586
immunosuppressive agents - therapeutic use (1581) 1581
immunoglobulin g - therapeutic use (1556) 1556
receptors, tumor necrosis factor - therapeutic use (1547) 1547
antibodies, monoclonal - administration & dosage (1537) 1537
pharmacology & pharmacy (1537) 1537
risk factors (1515) 1515
tumor necrosis factor (1455) 1455
necrosis-factor-alpha (1440) 1440
tumor necrosis factor-α (1421) 1421
gastrointestinal agents - therapeutic use (1393) 1393
medicine & public health (1386) 1386
patients (1369) 1369
drug therapy, combination (1337) 1337
safety (1336) 1336
antirheumatic agents - adverse effects (1308) 1308
disease (1304) 1304
infliximab - therapeutic use (1258) 1258
follow-up studies (1214) 1214
ulcerative-colitis (1209) 1209
antibodies, monoclonal, humanized (1189) 1189
colitis, ulcerative - drug therapy (1174) 1174
immunology (1162) 1162
child (1152) 1152
medical research (1148) 1148
medicine, general & internal (1123) 1123
tumor-necrosis-factor (1122) 1122
trial (1106) 1106
inflammation (1054) 1054
medicine, experimental (1041) 1041
dosage and administration (1037) 1037
analysis (1033) 1033
prospective studies (1012) 1012
time factors (1008) 1008
remission (1006) 1006
animals (997) 997
inflammatory bowel diseases - drug therapy (995) 995
surgery (991) 991
management (986) 986
tumor necrosis factor-tnf (986) 986
tumor necrosis factor-alpha - immunology (981) 981
azathioprine (972) 972
health aspects (962) 962
tnf-alpha (959) 959
ankylosing spondylitis (946) 946
remission induction (925) 925
psoriasis - drug therapy (919) 919
diagnosis (907) 907
antibodies, monoclonal, humanized - therapeutic use (889) 889
methotrexate - therapeutic use (887) 887
monoclonal-antibody (867) 867
rheumatoid factor (822) 822
inflammatory bowel diseases (808) 808
children (800) 800
placebo-controlled trial (800) 800
complications and side effects (798) 798
crohn disease - complications (783) 783
antibodies (782) 782
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (21103) 21103
Spanish (447) 447
French (415) 415
German (400) 400
Japanese (290) 290
Korean (146) 146
Russian (103) 103
Portuguese (77) 77
Italian (75) 75
Polish (74) 74
Hungarian (40) 40
Danish (38) 38
Czech (36) 36
Turkish (31) 31
Dutch (27) 27
Chinese (25) 25
Croatian (14) 14
Slovak (12) 12
Hebrew (9) 9
Swedish (6) 6
Finnish (5) 5
Norwegian (5) 5
Icelandic (3) 3
Persian (2) 2
Romanian (2) 2
Serbian (2) 2
Greek (1) 1
Lithuanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
La Revue de medecine interne, ISSN 0248-8663, 12/2017, Volume 38, p. A164
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.revmed.2017.10.117... 
Infliximab
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 12/2017, Volume 38, p. A163
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.revmed.2017.10.116 Il... 
Infliximab
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 12/2016, Volume 37, p. A266-A267
L'infliximab est un anticorps monoclonal chimerique (humain-murin) qui a montre des effets therapeutiques spectaculaires chez les patients atteints de... 
Infliximab
Journal Article
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 12/2014, Volume 35, p. A113-A114
Les uveites chroniques non infectieuses representent un defi therapeutique pour l'interniste. Le traitement repose sur la corticotherapie et les... 
Infliximab
Journal Article
Revue du rhumatisme, ISSN 1169-8330, 12/2015, Volume 82, Issue 6, p. 411
L'hidrosadenite suppuree (HS) severe, traitee par infliximab, peut etre associee a differentes formes de manifestation articulaire inflammatoire dont le... 
Infliximab
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 12/2015, Volume 36, p. A93
Les anti-TNF alpha sont rentres dans l'arsenal therapeutique des uveites inflammatoires severes. Cependant, il existe tres peu de donnees comparant... 
Infliximab
Journal Article
Journal Article
Journal of Pediatric Gastroenterology and Nutrition, ISSN 0277-2116, 04/2017, Volume 64, Issue 4, pp. 580 - 585
Journal Article
Gut, ISSN 0017-5749, 10/2015, Volume 64, Issue 10, pp. 1539 - 1545
Journal Article
Revue du rhumatisme, ISSN 1169-8330, 12/2014, Volume 81, Issue 6, p. 483
Comparer les taux de retention de l'adalimumab, de l'etanercept et de l'infliximab en tant que biotherapie de 1.sup.re intention dans la polyarthrite... 
Infliximab
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 01/2017, Volume 76, Issue 1, pp. 58 - 64
Journal Article
Arthritis Research and Therapy, ISSN 1478-6354, 01/2016, Volume 18, Issue 1, pp. 25 - 25
Background: CT-P13 (Remsima (R), Inflectra (R)) is a biosimilar of the infliximab reference product (RP; Remicade (R)) and is approved in Europe and elsewhere,... 
Immunogenicity | Infliximab | Clinical trial | Efficacy | ASAS | Safety | CT-P13 | Pharmacokinetics | Ankylosing spondylitis | Biosimilar | MULTICENTER | INNOVATOR INFLIXIMAB | ACTIVE RHEUMATOID-ARTHRITIS | METHOTREXATE | MONOCLONAL-ANTIBODY | RHEUMATOLOGY | 2010 UPDATE | SPONDYLOARTHRITIS | RECOMMENDATIONS | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Infliximab - therapeutic use | Infliximab - pharmacokinetics | Young Adult | Infliximab - adverse effects | Antirheumatic Agents - adverse effects | Biosimilar Pharmaceuticals - pharmacokinetics | Adult | Female | Neutropenia - chemically induced | Antirheumatic Agents - therapeutic use | Biosimilar Pharmaceuticals - therapeutic use | Double-Blind Method | Spondylitis, Ankylosing - drug therapy | Antibodies, Monoclonal - pharmacokinetics | Treatment Outcome | Spondylitis, Ankylosing - metabolism | Biosimilar Pharmaceuticals - adverse effects | Self Report - standards | Spondylitis, Ankylosing - diagnosis | Internationality | Adolescent | Antirheumatic Agents - pharmacokinetics | Aged | Chemical and Drug Induced Liver Injury | Longitudinal Studies | Complications and side effects | Usage | Patient outcomes | Outcome and process assessment (Health Care) | Dosage and administration | Research | Drug therapy | Methods | Index Medicus
Journal Article
Journal Article
Journal Article